Details for New Drug Application (NDA): 205291
✉ Email this page to a colleague
The generic ingredient in CETIRIZINE HYDROCHLORIDE ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-eight suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Summary for 205291
| Tradename: | CETIRIZINE HYDROCHLORIDE ALLERGY |
| Applicant: | Onesource Specialty |
| Ingredient: | cetirizine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 205291
| Mechanism of Action | Histamine H1 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 205291
Suppliers and Packaging for NDA: 205291
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | CAPSULE;ORAL | 205291 | ANDA | Care One (American Sales Company) | 41520-212 | 41520-212-25 | 1 BOTTLE, PLASTIC in 1 BOX (41520-212-25) / 25 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC |
| CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | CAPSULE;ORAL | 205291 | ANDA | WALMART INC. (see also Equate) | 79903-344 | 79903-344-25 | 1 BOTTLE, PLASTIC in 1 BOX (79903-344-25) / 25 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Jul 21, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
